130 related articles for article (PubMed ID: 19338533)
21. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic and ethical problems of nephrostomy in tumor-related hydronephrosis].
Tauber R; Groos E; Zink RA
Urologe A; 1985 Nov; 24(6):320-2. PubMed ID: 2418568
[TBL] [Abstract][Full Text] [Related]
23. Systemic chemotherapy in patients with indwelling ureteral stenting.
Oh SJ; Ku JH; Byun SS; Lee SW; Jeon HG; Kim HH
Int J Urol; 2005 Jun; 12(6):548-51. PubMed ID: 15985076
[TBL] [Abstract][Full Text] [Related]
24. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
Ghobrial IM; Fonseca R; Gertz MA; Plevak MF; Larson DR; Therneau TM; Wolf RC; Hoffmann RJ; Lust JA; Witzig TE; Lacy MQ; Dispenzieri A; Vincent Rajkumar S; Zeldenrust SR; Greipp PR; Kyle RA
Br J Haematol; 2006 Apr; 133(2):158-64. PubMed ID: 16611306
[TBL] [Abstract][Full Text] [Related]
25. Predictors of adverse surgical outcome in the management of malignant bowel obstruction.
Medina-Franco H; García-Alvarez MN; Ortiz-López LJ; Cuairán JZ
Rev Invest Clin; 2008; 60(3):212-6. PubMed ID: 18807733
[TBL] [Abstract][Full Text] [Related]
26. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
Bell DG; Fischer MA
Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
[TBL] [Abstract][Full Text] [Related]
27. Ureteric embolization with stainless-steel coils for managing refractory lower urinary tract fistula: a 12-year experience.
Shindel AW; Zhu H; Hovsepian DM; Brandes SB
BJU Int; 2007 Feb; 99(2):364-8. PubMed ID: 17026590
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
29. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review.
Carrafiello G; Laganà D; Mangini M; Lumia D; Recaldini C; Bacuzzi A; Marconi A; Mira A; Cuffari S; Fugazzola C
Radiol Med; 2006 Jun; 111(4):562-71. PubMed ID: 16779542
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous endopyelotomy for secondary ureteropelvic junction obstruction: prognostic factors affecting late recurrence.
El-Nahas AR; Shoma AM; Eraky I; El-Kenawy MR; El-Kappany HA
Scand J Urol Nephrol; 2006; 40(5):385-90. PubMed ID: 17060085
[TBL] [Abstract][Full Text] [Related]
31. Severe complications limit long-term clinical success of self-expanding metal stents in patients with obstructive colorectal cancer.
Fernández-Esparrach G; Bordas JM; Giráldez MD; Ginès A; Pellisé M; Sendino O; Martínez-Pallí G; Castells A; Llach J
Am J Gastroenterol; 2010 May; 105(5):1087-93. PubMed ID: 19935785
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
Pothuri B; Montemarano M; Gerardi M; Shike M; Ben-Porat L; Sabbatini P; Barakat RR
Gynecol Oncol; 2005 Feb; 96(2):330-4. PubMed ID: 15661217
[TBL] [Abstract][Full Text] [Related]
33. Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma.
Shulman MJ; Benaim EA
Cancer; 2005 Jun; 103(11):2280-6. PubMed ID: 15844202
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors of mortality in the malignant biliary obstruction unresectable after the insertion of an endoscopic stent].
Hernández Guerrero A; Sánchez del Monte J; Sobrino Cossío S; Alonso Lárraga O; Delgado de la Cruz L; Frías Mendívil MM; Frías Mendívil CM
Rev Gastroenterol Mex; 2006; 71(1):22-30. PubMed ID: 17063571
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
[TBL] [Abstract][Full Text] [Related]
36. Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors.
Kripp M; Willer A; Schmidt C; Pilz LR; Gencer D; Buchheidt D; Hochhaus A; Hofmann WK; Hofheinz RD
Ann Hematol; 2014 Feb; 93(2):317-25. PubMed ID: 23925929
[TBL] [Abstract][Full Text] [Related]
37. Hydronephrosis associated with colorectal carcinoma: treatment and outcome.
Lev-Chelouche D; Keidar A; Rub R; Matzkin H; Gutman M
Eur J Surg Oncol; 2001 Aug; 27(5):482-6. PubMed ID: 11504520
[TBL] [Abstract][Full Text] [Related]
38. [Palliative urinary diversion in inoperable pelvic tumors].
Olivo JF; Le Joliff L; Artagnan J; Lobel B
J Urol (Paris); 1987; 93(6):353-5. PubMed ID: 2448387
[TBL] [Abstract][Full Text] [Related]
39. [Percutaneous nephrostomy in malignant ureteral obstruction].
Demetriou D; Sebeikat D
Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
[TBL] [Abstract][Full Text] [Related]
40. Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?
Harris MR; Speakman MJ
Prostate Cancer Prostatic Dis; 2006; 9(1):42-4. PubMed ID: 16402089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
